Statement Of Financial Position [Abstract]

Pharming Group N.V. - Filing #5829944

Concept	As at 2024-12-31	As at 2024-12-31	As at 2024-12-31	As at 2024-12-31	As at 2024-12-31	As at 2023-12-31	As at 2023-12-31	As at 2023-12-31	As at 2023-12-31	As at 2023-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31
Statement of financial position [abstract]
Assets [abstract]
Property, plant and equipment	—	—	—	7,752,000 USD	—	—	—	—	9,689,000 USD	—	—	—	—	—	—
Right-of-use assets	—	—	—	16,382,000 USD	—	—	—	—	23,777,000 USD	—	—	—	—	—	—
Intangible assets other than goodwill	—	—	—	61,039,000 USD	—	—	—	—	71,267,000 USD	—	—	—	—	—	—
Investments accounted for using equity method	—	—	—	466,000 USD	—	—	—	—	2,285,000 USD	—	—	—	—	—	—
Deferred tax assets	—	—	—	30,544,000 USD	—	—	—	—	29,761,000 USD	—	—	—	—	—	—
Cash and cash equivalents	—	—	—	54,944,000 USD	—	—	—	—	61,741,000 USD	—	207,342,000 USD	—	—	—	—
Assets	—	—	—	399,985,000 USD	—	—	—	—	462,854,000 USD	—	—	—	—	—	—
Equity and liabilities [abstract]
Equity [abstract]
Issued capital	—	—	—	7,769,000 USD	—	—	—	—	7,669,000 USD	—	—	—	—	—	—
Retained earnings	—	—	—	275,489,000 USD	—	—	—	—	265,262,000 USD	—	—	—	—	—	—
Share premium	—	—	—	488,990,000 USD	—	—	—	—	478,431,000 USD	—	—	—	—	—	—
Other reserves	—	—	—	209,000 USD	—	—	—	—	2,057,000 USD	—	—	—	—	—	—
Equity	275,489,000 USD	488,990,000 USD	209,000 USD	221,061,000 USD	7,769,000 USD	478,431,000 USD	7,669,000 USD	265,262,000 USD	218,781,000 USD	2,057,000 USD	204,638,000 USD	462,297,000 USD	7,509,000 USD	256,431,000 USD	8,737,000 USD
Equity and liabilities	—	—	—	399,985,000 USD	—	—	—	—	462,854,000 USD	—	—	—	—	—	—